| Product Code: ETC9940691 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Chimeric Antigen Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Chimeric Antigen Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Chimeric Antigen Market - Industry Life Cycle |
3.4 United Kingdom (UK) Chimeric Antigen Market - Porter's Five Forces |
3.5 United Kingdom (UK) Chimeric Antigen Market Revenues & Volume Share, By Target Antigen, 2021 & 2031F |
3.6 United Kingdom (UK) Chimeric Antigen Market Revenues & Volume Share, By Target Antigen, 2021 & 2031F |
3.7 United Kingdom (UK) Chimeric Antigen Market Revenues & Volume Share, By End-Use, 2021 & 2031F |
4 United Kingdom (UK) Chimeric Antigen Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in the UK |
4.2.2 Growing investment in research and development of immunotherapy |
4.2.3 Rising adoption of personalized medicine in cancer treatment |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of chimeric antigen therapies |
4.3.2 High cost associated with chimeric antigen therapy development and treatment |
4.3.3 Limited awareness and accessibility of chimeric antigen therapies in the UK healthcare system |
5 United Kingdom (UK) Chimeric Antigen Market Trends |
6 United Kingdom (UK) Chimeric Antigen Market, By Types |
6.1 United Kingdom (UK) Chimeric Antigen Market, By Target Antigen |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Chimeric Antigen Market Revenues & Volume, By Target Antigen, 2021- 2031F |
6.1.3 United Kingdom (UK) Chimeric Antigen Market Revenues & Volume, By CD19, 2021- 2031F |
6.1.4 United Kingdom (UK) Chimeric Antigen Market Revenues & Volume, By CD22, 2021- 2031F |
6.1.5 United Kingdom (UK) Chimeric Antigen Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) Chimeric Antigen Market, By Target Antigen |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Chimeric Antigen Market Revenues & Volume, By CD19, 2021- 2031F |
6.2.3 United Kingdom (UK) Chimeric Antigen Market Revenues & Volume, By CD22, 2021- 2031F |
6.2.4 United Kingdom (UK) Chimeric Antigen Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United Kingdom (UK) Chimeric Antigen Market, By End-Use |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Chimeric Antigen Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United Kingdom (UK) Chimeric Antigen Market Revenues & Volume, By Cancer Research Centres, 2021- 2031F |
6.3.4 United Kingdom (UK) Chimeric Antigen Market Revenues & Volume, By Clinics, 2021- 2031F |
7 United Kingdom (UK) Chimeric Antigen Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Chimeric Antigen Market Export to Major Countries |
7.2 United Kingdom (UK) Chimeric Antigen Market Imports from Major Countries |
8 United Kingdom (UK) Chimeric Antigen Market Key Performance Indicators |
8.1 Patient response rates to chimeric antigen therapies |
8.2 Number of clinical trials for chimeric antigen therapies in the UK |
8.3 Percentage of oncologists recommending chimeric antigen therapy as a treatment option |
9 United Kingdom (UK) Chimeric Antigen Market - Opportunity Assessment |
9.1 United Kingdom (UK) Chimeric Antigen Market Opportunity Assessment, By Target Antigen, 2021 & 2031F |
9.2 United Kingdom (UK) Chimeric Antigen Market Opportunity Assessment, By Target Antigen, 2021 & 2031F |
9.3 United Kingdom (UK) Chimeric Antigen Market Opportunity Assessment, By End-Use, 2021 & 2031F |
10 United Kingdom (UK) Chimeric Antigen Market - Competitive Landscape |
10.1 United Kingdom (UK) Chimeric Antigen Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Chimeric Antigen Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here